scispace - formally typeset
B

Barbara Blanco-Fernandez

Researcher at Michigan State University

Publications -  25
Citations -  986

Barbara Blanco-Fernandez is an academic researcher from Michigan State University. The author has contributed to research in topics: Drug delivery & Drug carrier. The author has an hindex of 12, co-authored 21 publications receiving 692 citations. Previous affiliations of Barbara Blanco-Fernandez include University of Santiago de Compostela & University of Aveiro.

Papers
More filters
Journal ArticleDOI

Crosslinked ionic polysaccharides for stimuli-sensitive drug delivery.

TL;DR: The state of the art of crosslinked ionic polysaccharides as components of delivery systems that can regulate drug release as a function of changes in pH, ion nature and concentration, electric and magnetic field intensity, light wavelength, temperature, redox potential, and certain molecules are analyzed.
Journal ArticleDOI

Synthesis of temperature-responsive dextran-MA/PNIPAAm particles for controlled drug delivery using superhydrophobic surfaces.

TL;DR: The proposed method permitted the preparation of smart hydrogel particles in one step with almost 100% encapsulation yield and the temperature-sensitive release profiles suggest that the obtained spherical-shaped biomaterials are suitable as protein carriers.
Journal ArticleDOI

Synergistic performance of cyclodextrin–agar hydrogels for ciprofloxacin delivery and antimicrobial effect

TL;DR: Microbiological tests with Gram-negative and Gram-positive bacteria confirmed the suitability of the “green” CD–agar hydrogels for the development of drug delivery systems with tunable physical and drug loading/release properties.
Journal ArticleDOI

Hydrophobically Modified Keratin Vesicles for GSH-Responsive Intracellular Drug Release.

TL;DR: The proposed keratin polymersomes could be efficient nanocarriers for chemotherapeutic agents and inhibited HeLa and CHO-K1 cancer cells proliferation.
Journal ArticleDOI

Nanotechnology Approaches in Chronic Wound Healing

TL;DR: This review focuses on the most recently developed nanotechnology- base therapeutic agents and evaluates the efficacy of each treatment In in vivo diabetic models of chronic wound healing.